These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30620709)

  • 1. Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations.
    Hannon AM; O'Shea T; Thompson CA; Hannon MJ; Dineen R; Khattak A; Gibney J; O'Halloran DJ; Hunter S; Thompson CJ; Sherlock M
    Eur J Endocrinol; 2019 Apr; 180(4):K21-K29. PubMed ID: 30620709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in acromegaly: a one-center experience.
    Cozzi R; Attanasio R; Barausse M
    Eur J Endocrinol; 2006 Aug; 155(2):279-84. PubMed ID: 16868141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational diabetes and acromegaly: Single-centre experience of 14 pregnancies.
    Vialon M; Grunenwald S; Mouly C; Vezzosi D; Bennet A; Gourdy P; Caron PJ
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):805-809. PubMed ID: 31520541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
    Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of pregnancies in a large cohort of women with acromegaly.
    Jallad RS; Shimon I; Fraenkel M; Medvedovsky V; Akirov A; Duarte FH; Bronstein MD
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):896-907. PubMed ID: 29574986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery.
    Okada Y; Morimoto I; Ejima K; Yoshida K; Kashimura M; Fujihira T; Eto S
    Endocr J; 1997 Feb; 44(1):117-20. PubMed ID: 9152623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of GH and IGF-1 levels following withdrawal of long-acting octreotide in acromegaly.
    Lorcy Y; Dejager S; Chanson P;
    Pituitary; 2000 Nov; 3(3):193-7. PubMed ID: 11383486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?
    Rosario PW; Calsolari MR
    Arch Endocrinol Metab; 2015 Feb; 59(1):54-8. PubMed ID: 25926115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval.
    Biermasz NR; van den Oever NC; Frölich M; Arias AM; Smit JW; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):288-95. PubMed ID: 12608933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide use for rescue of vision in a pregnant patient with acromegaly.
    Hannon AM; Frizelle I; Kaar G; Hunter SJ; Sherlock M; Thompson CJ; O'Halloran DJ;
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31117051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course and outcomes of pregnancy in women treated for acromegaly: Discerning a contemporary cohort.
    Das L; Dutta P; Thirunavukkarasu B; Gupta K; Tripathi M; Gupta P; Aggarwal N; Rai A; Radotra BD; Bhansali A; Suri V
    Growth Horm IGF Res; 2021; 60-61():101417. PubMed ID: 34271296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
    Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
    Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C; Fluiters E; de la Fuente J; Andrade A; García-Mayor RV
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.